---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-009393"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2025-02-05T23:59:59+00:00"
generated_at: "2026-05-27T02:49:21.412069+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed appoints former Medtronic SVP Chris Cleary to board; Dr. Eric Rose resigns as director

## Summary
- Chris Cleary appointed as Class II independent director effective Jan 30, 2025; board expanded to nine.
- Cleary was Medtronic SVP of Corporate Development, led $50B Covidien acquisition and $6B asset sale to Cardinal Health.
- Cleary previously helped shape Orchestra BioMed's AVIM therapy strategic collaboration with Medtronic.
- Eric Rose resigned as director Feb 3, 2025; remains as Emeritus Board Member and Strategic Advisor.
- Board expected to decrease to eight members following Rose resignation.

## SEC filing metadata
- accession: 0001104659-25-009393
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2025-02-05T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000110465925009393/0001104659-25-009393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000110465925009393/tm255461d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-009393
- JSON: https://secwatch.observer/filing/0001104659-25-009393.json
- Plain text: https://secwatch.observer/filing/0001104659-25-009393.txt

## Key facts
- Executive change
  Chris Cleary was appointed as Class II director at Orchestra BioMed Holdings, Inc..
  - Action: appointed
  - Role: Class II director
  source text: appointed Chris Cleary to serve as a Class II director, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1814114/000110465925009393/0001104659-25-009393-index.htm
- Executive change
  Eric Rose resigned as director at Orchestra BioMed Holdings, Inc..
  - Action: resigned
  - Role: director
  source text: On February 3, 2025, Eric Rose, M.D., notified the Company of his resignation from the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1814114/000110465925009393/0001104659-25-009393-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.